Cargando…
Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma
Gastric cancer (GC) is considered lethal aggressive cancer. In Egypt, GC has a low incidence but unfortunately, it is mostly diagnosed at an advanced stage with a poor prognosis. Assessment of novel markers that can be used in the early detection of GC is an urgent need. The present study was perfor...
Autores principales: | Abdel-Tawab, Marwa Sayed, Fouad, Hanan, Othman, Asmaa M., Eid, Ragaey A., Mohammed, Marwa Abdeltawab, Hassan, Ahmed, Reyad, Hoda Ramadan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022821/ https://www.ncbi.nlm.nih.gov/pubmed/35446856 http://dx.doi.org/10.1371/journal.pone.0265184 |
Ejemplares similares
-
Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy
por: Abdel-Tawab, Marwa Sayed, et al.
Publicado: (2023) -
Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer
por: Wang, Yufei, et al.
Publicado: (2022) -
PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer
por: Pignot, Géraldine, et al.
Publicado: (2019) -
PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
por: Xing, Xiangling, et al.
Publicado: (2020) -
Demographic, clinical, and laboratory characteristics of patients with COVID-19 during the second and third waves of the pandemic in Egypt
por: Eid, Ragaey A., et al.
Publicado: (2021)